Thompson Davis & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$32K Buy
+600
New +$30.7K 0.07% 265
2017
Q4
Sell
-401
Closed -$27K 729
2017
Q3
$27K Buy
401
+96
+31% +$6.79K 0.05% 379
2017
Q2
$24K Hold
305
0.04% 391
2017
Q1
$25K Sell
305
-22
-7% -$1.73K 0.04% 415
2016
Q4
$24K Hold
327
0.04% 428
2016
Q3
$25K Sell
327
-4
-1% -$323 0.04% 398
2016
Q2
$26K Hold
331
0.04% 386
2016
Q1
$27K Sell
331
-737
-69% -$59.9K 0.04% 358
2015
Q4
$95K Buy
1,068
+245
+30% +$20.8K 0.13% 166
2015
Q3
$63K Sell
823
-388
-32% -$32.4K 0.09% 215
2015
Q2
$101K Hold
1,211
0.12% 194
2015
Q1
$109K Buy
1,211
+363
+43% +$31.3K 0.13% 168
2014
Q4
$68K Buy
848
+223
+36% +$17.6K 0.08% 230
2014
Q3
$47K Buy
625
+250
+67% +$18.2K 0.06% 274
2014
Q2
$26K Sell
375
-500
-57% -$34K 0.04% 342
2014
Q1
$61K Buy
875
+625
+250% +$43.5K 0.1% 223
2013
Q4
$17K Buy
+250
New +$15.3K 0.03% 368

Other funds holding CAH

Thompson Davis & Co's CAH Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Cardinal Health (CAH) in Q3 2018: 600 shares worth $32K. The stake represents 0.07% of the portfolio and ranks #265 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in CAH as recently as Q3 2017.

Thompson Davis & Co first reported a position in CAH in Q4 2013 and has held it in 17 quarters since. The position peaked at $109K in Q1 2015. 685 funds tracked by Wall St. Rank hold CAH as of Q3 2018.

  • Thompson Davis & Co held 600 shares of Cardinal Health worth $32K as of Q3 2018.
  • Cardinal Health was a new Thompson Davis & Co position in Q3 2018.
  • Cardinal Health made up 0.07% of Thompson Davis & Co's portfolio in Q3 2018, its #265 holding.
  • Thompson Davis & Co first reported a position in Cardinal Health in Q4 2013 and has held it in 17 quarters since.
  • Thompson Davis & Co's Cardinal Health position peaked at $109K in Q1 2015.
  • 685 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.